🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.

Several professionals said the popularity for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has removed problematic content and banned associated keywords and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also found communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of slimming results, positive testimonials and detailed instructions for mixing or injecting at home.

Within minutes of entering one community, a vendor posted contact information, where the majority of purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.

Item Details and Costs

Inside these groups, posts show black plastic packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Although the science behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially serious medical dangers”.